A Study of Nivolumab +/- Nab-paclitaxel in Non-small Cell Lung Cancer

NCT02967133 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Lack of enrollment

Conditions

Non-Small-Cell Lung Cancer Metastatic
Non-Small Cell Carcinoma of Lung, TNM Stage 4
Nonsmall Cell Lung Cancer
Non Small Cell Lung Cancer Recurrent

Interventions

DRUG: Nivolumab
DRUG: nab-paclitaxel

Sponsor

Alliance Foundation Trials, LLC.

Collaborators

[object Object]
[object Object]